Boram Han Selected Research

Boram Han Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 04/2011
6	Stomach Neoplasms (Stomach Cancer) 01/2019 - 07/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2011
3	Adenocarcinoma 01/2021 - 04/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019 - 05/2012
3	Disease Progression 03/2015 - 07/2011
2	Thrombocytopenia (Thrombopenia) 07/2022 - 01/2015
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2018
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2018 - 04/2015
2	Neutropenia 01/2015 - 10/2013
2	Anemia 08/2014 - 10/2013
2	Sarcoma (Soft Tissue Sarcoma) 04/2011 - 01/2011
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 07/2022
1	Hypersensitivity (Allergy) 01/2022
1	Eosinophilia 01/2019
1	Wounds and Injuries (Trauma) 04/2017
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 11/2016
1	Pneumonia (Pneumonitis) 06/2015
1	Renal Insufficiency (Renal Failure) 08/2014
1	Hypercalcemia (Milk Alkali Syndrome) 08/2014
1	Fibrosis (Cirrhosis) 05/2014
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2014
1	Injection Site Reaction 01/2014
1	Febrile Neutropenia 01/2014
1	Multiple Myeloma 01/2014
1	Malnutrition (Nutritional Deficiencies) 01/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2014
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2014
1	Vomiting 09/2013
1	Nausea 09/2013
1	Neoplasm Metastasis (Metastasis) 03/2013
1	Critical Illness (Critically Ill) 02/2013
1	Respiratory Insufficiency (Respiratory Failure) 02/2013
1	Meningeal Carcinomatosis 05/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 12/2011
1	Colonic Neoplasms (Colon Cancer) 04/2011

Drug/Important Bio-Agent (IBA)

7	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2018 - 01/2015
6	Irinotecan (Camptosar)FDA LinkGeneric 10/2018 - 07/2011
4	Gemcitabine FDA Link 01/2021 - 10/2013
3	Decitabine FDA Link 01/2020 - 01/2018
3	ErbB Receptors (EGF Receptor)IBA 02/2019 - 04/2011
3	Cisplatin (Platino)FDA LinkGeneric 10/2018 - 07/2011
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 07/2011
3	Docetaxel (Taxotere)FDA Link 04/2016 - 07/2011
3	Leucovorin (Folinic Acid)FDA Link 01/2016 - 07/2011
3	Capecitabine (Xeloda)FDA Link 03/2015 - 07/2011
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 02/2019 - 05/2014
2	S 1 (combination)IBA 04/2016 - 04/2015
2	Anaplastic Lymphoma KinaseIBA 02/2013 - 05/2012
2	CrizotinibIBA 02/2013 - 05/2012
1	Inosine Triphosphate (ITP)IBA 07/2022
1	AntigensIBA 01/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2019
1	PlatinumIBA 01/2018
1	A-factor (Streptomyces)IBA 04/2017
1	Peptide Nucleic AcidsIBA 04/2015
1	XELOXIBA 01/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2014
1	ChitinasesIBA 05/2014
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2014
1	AmphiregulinIBA 05/2014
1	LigandsIBA 05/2014
1	chitotriosidaseIBA 05/2014
1	Transferrin (beta 2 Transferrin)IBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014
1	Prealbumin (Transthyretin)IBA 01/2014
1	Prednisone (Sone)FDA LinkGeneric 01/2014
1	Rituximab (Mabthera)FDA Link 01/2014
1	Bortezomib (Velcade)FDA Link 01/2014
1	AlbuminsIBA 01/2014
1	Serum AlbuminIBA 01/2014
1	Vincristine (Oncovin)FDA LinkGeneric 01/2014
1	Aprepitant (Emend)FDA Link 09/2013
1	SteroidsIBA 09/2013
1	Serotonin AntagonistsIBA 09/2013
1	ramosetron (Nasea)IBA 09/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2013
1	Investigational DrugsIBA 05/2012
1	Methotrexate (Mexate)FDA LinkGeneric 05/2012
1	TOR Serine-Threonine KinasesIBA 07/2011
1	Everolimus FDA Link 07/2011
1	Cetuximab (Erbitux)FDA Link 04/2011
1	Monoclonal AntibodiesIBA 04/2011
1	Simvastatin (Zocor)FDA LinkGeneric 04/2011
1	Mesna (Coenzyme M)FDA LinkGeneric 01/2011

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
6	Therapeutics 01/2018 - 11/2009
1	Patient Readmission 06/2015
1	Physical Therapy Modalities (Physical Therapy Technique) 06/2015
1	Intravenous Administration 01/2014
1	Combination Drug Therapy (Combination Chemotherapy) 10/2013
1	Palliative Care (Palliative Therapy) 03/2013
1	Aftercare (After-Treatment) 02/2013
1	Artificial Respiration (Mechanical Ventilation) 02/2013